English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAt the end of 2020, with announcement of the impending approval of two vaccines against COVID-19, AANEM staff faced a sudden influx of phone calls and emails from members, nonmember physicians, and even some neuromuscular (NM) patients inquiring about the safety of such vaccines for NM patients. The AANEM Quality & Patient Safety Committee quickly took up the task of researching the data available on the COVID-19 vaccines, as well as looking at the safety and efficacy of vaccines in general in this patient population.
“The AANEM Quality & Patienty Safety Committee has been absolutely incredible to work with during the COVID-19 pandemic,” said Millie Suk, JD, AANEM’s Health Policy Director.
In mid-January, the AANEM Quality & Patient Safety committee published a paper called “Doctor – Should I get the COVID-19 vaccine? Infection and Immunization in Individuals with Neuromuscular Disorders.”
“They quickly took the issue and ran with it, feverishly scouring the available research and pulling together a solid document based on the most current evidence. This guidance document addresses both the safety and efficacy of the COVID-19 vaccines, and vaccines in general, for the NM population,” said Suk.
“Doctor – Should I get the COVID-19 vaccine? Infection and Immunization in Individuals with Neuromuscular Disorders” can be found at: https://www.aanem.org/Practice/COVID-19-Guidance.
About AANEM
Based in Rochester, Minnesota, the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is the premier nonprofit membership association dedicated to the advancement of neuromuscular (NM), musculoskeletal and electrodiagnostic (EDX) medicine. The organization and its members work to improve the quality of patient care and advance the science of NM diseases and EDX medicine by serving physicians and allied health professionals who care for those with muscle and nerve disorders.
